Remove Article Remove DEA Remove Safety
article thumbnail

ASA Newsletter-September 2024

Americans for Safe Access

ASA has recently revamped our Member Benefits Program, adding new benefits for our members each month like the 20% off offer on Nectar Products (see article below on Nectar) & 50% off registration for the upcoming Validated Voices Summit in September. A Patient & Consumer Guide to Navigating Cannabis Safety.

DEA 147
article thumbnail

Federal vs. State Approaches to Cannabis: Recent DEA Data Shows Increase In Enforcement While States Move Toward Decriminalization and Legalization

The Blunt Truth

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chacruna: Ayahuasca FOIA Requests Reveal Increased Ayahuasca Seizures, Lack of Due Process and Government Secrecy

Cannabis Law Report

This article reviews the insights gained to date from the government’s disclosures, or lack thereof, to the Initiative’s public records requests. Drug Enforcement Agency (“DEA”). While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. Best, [name redacted].

DEA 97
article thumbnail

Is The DEA Poised To Regulate Telepharmacy?

Cannabis Law Report

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51
article thumbnail

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45
article thumbnail

New Hemp Testing Guidelines Make Meeting 0.3% THC Limit Difficult

Medicinal Genomics

This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. What does this mean for hemp farmers? THC threshold.

THC 81